MiSight®

Image of MiSight-1-Day-Contact-Lens box

MiSight® 1 day is the innovative lens that goes beyond vision correction

MiSight® 1 day is the first and only contact lens FDA-approved to slow the progression of myopia^* in children age 8-12 at initiation of treatment.^**

CLINICALLY PROVEN OUTCOMES:

59% average reduction in SERE with MiSight® 1 day lenses^1**
52% average reduction in axial lengthening with MiSight® 1 day lenses^1**
9 out of 10 children wearing MiSight® 1 day lenses report seeing well while doing schoolwork while playing outdoors, and while looking at a computer screen/playing video games.^2†‡

The MiSight® 1 day lens is the cornerstone of the Brilliant FuturesTM Myopia Management Program, a comprehensive myopia management approach offered by CooperVision®.

HOW MISIGHT® 1 DAY WORKS:

The ActivControlTM technology in MiSight® 1 day uses vision correction zones and treatment zones within the lenses to slow axial elongation.^1-3
By including both types of zones in the lens, it simultaneously corrects the child’s vision today, while creating myopic defocus in all gazes.¹

Want to learn more?

View the Fact Sheet here.
Read When Children Can’t See Far: A Disccusion About Pediatric Myopia here.

Check to see if your child could benefit from MiSight® 1 day lens today! Schedule an appointment at Ben Popilsky, OD today.

Indications for use: MiSight® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation
of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.

_{*Indications for use: MiSight® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.

** Compared to a single vision 1 day lens over a 3 year period. † From 1 month through 3 year visits

‡ From 1 week through 3 year visits

REFERENCES: 1. Chamberlain P, et al. A 3-year Randomized Clinical Trial of MiSight Lenses for Myopia Control. Optom Vis Sci. 2019;96(8):556–567. 2. Sulley A et al, Wearer experience and subjective responses with dual focus compared to spherical, single vision soft contact lenses in children during a 3-year clinical trial. AAO 2019 Poster Presentation.

REFERENCES: 1. Chamberlain P, et al. A 3-year randomized clinical trial of MiSight® lenses for myopia control. Optom Vis Sci. 2019; 96(8):556–567. 2. La liste des nominés aux 26e SILMO d’Or. (2019, September 25). Retrieved October 2, 2019, from https:// en.silmoparis.com/Silmo-d-Or-Awards/Nominees-2019. 3. Optician. (2018, April 4). Optician Awards 2018: Black ties and glittering prizes. Retrieved October 2, 2019, from https://www.opticianonline.net/news/optician-awards-2018- black-ties-and-glittering prizes.}